Cardiol Therapeutics Inc
TSX:CRDL

Watchlist Manager
Cardiol Therapeutics Inc Logo
Cardiol Therapeutics Inc
TSX:CRDL
Watchlist
Price: 1.79 CAD Market Closed
Market Cap: 147.9m CAD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of CRDL.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CRDL Intrinsic Value
Not Available
Base Case Scenario
Compare CRDL to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CRDL?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Cardiol Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cardiol Therapeutics Inc

Current Assets 25.3m
Cash & Short-Term Investments 23.3m
Receivables 346.7k
Other Current Assets 1.6m
Non-Current Assets 182.5k
PP&E 182.6k
Other Non-Current Assets -100
Efficiency

Free Cash Flow Analysis
Cardiol Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cardiol Therapeutics Inc

Revenue
0 CAD
Operating Expenses
-40.3m CAD
Operating Income
-40.3m CAD
Other Expenses
4.5m CAD
Net Income
-35.8m CAD
Fundamental Scores

CRDL Profitability Score
Profitability Due Diligence

Cardiol Therapeutics Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

35/100
Profitability
Score

Cardiol Therapeutics Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

CRDL Solvency Score
Solvency Due Diligence

Cardiol Therapeutics Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
64/100
Solvency
Score

Cardiol Therapeutics Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CRDL Price Targets Summary
Cardiol Therapeutics Inc

Wall Street analysts forecast CRDL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRDL is 9.95 CAD with a low forecast of 8.59 CAD and a high forecast of 11.55 CAD.

Lowest
Price Target
8.59 CAD
380% Upside
Average
Price Target
9.95 CAD
456% Upside
Highest
Price Target
11.55 CAD
545% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Cardiol Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CRDL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y